Page 73 - IMO-2-3

Innovative Medicines & Omics Peganum harmala and GLP-1: A natural approach

22. Holst JJ. The physiology of glucagon-like peptide 1. Physiol in standardized human islets using 3D high-content
Rev. 2007;87(4):1409-1439. confocal imaging and automated analysis. Front Endocrinol
(Lausanne). 2022;13:854094.
doi: 10.1152/physrev.00034.2006
doi: 10.3389/fendo.2022.854094
23. Hamed K, Alosaimi MN, Ali BA, et al. Glucagon-like
peptide-1 (GLP-1) receptor agonists: Exploring their impact 33. Modvig IM, Smits MM, Galsgaard KD, et al. L-valine is a
on diabetes, obesity, and cardiovascular health through a powerful stimulator of GLP-1 secretion in rodents and
comprehensive literature review. Cureus. 2024;16(9):e68390. stimulates secretion through ATP-sensitive potassium
channels and voltage-gated calcium channels. Nutr Diabetes.
doi: 10.7759/cureus.68390 2024;14(1):43.
24. Taktaz F, Fontanella RA, Scisciola L, et al. Bridging the doi: 10.1038/s41387-024-00303-4
gap between GLP1-receptor agonists and cardiovascular
outcomes: Evidence for the role of tirzepatide. Cardiovasc 34. Herraiz T, González D, Ancín-Azpilicueta C, Arán VJ,
Diabetol. 2024;23:242. Guillén H. beta-Carboline alkaloids in Peganum harmala
and inhibition of human monoamine oxidase (MAO). Food
doi: 10.1186/s12933-024-02319-7 Chem Toxicol. 2010;48(3):839-845.
25. Shu Y, He X, Wu P, Liu Y, Ding Y, Zhang Q. Gastrointestinal doi: 10.1016/j.fct.2009.12.019
adverse events associated with semaglutide:
A pharmacovigilance study based on FDA adverse event 35. Ernst AU, Bowers DT, Wang LH, et al. Nanotechnology in
reporting system. Front Public Health. 2022;10:996179. cell replacement therapies for type 1 diabetes. Adv Drug
Deliv Rev. 2019;139:116-138.
doi: 10.3389/fpubh.2022.996179
doi: 10.1016/j.addr.2019.01.013
26. Dagher C, Jailani M, Akiki M, Siddique T, Saleh Z, Nadler
E. Semaglutide-induced acute pancreatitis leading to death 36. Zeng Y, Wu Y, Zhang Q, Xiao X. Crosstalk between
after four years of use. Cureus. 2024;16(9):e69704. glucagon-like peptide 1 and gut microbiota in metabolic
diseases. mBio. 2024;15(1):e0203223.
doi: 10.7759/cureus.69704
doi: 10.1128/mbio.02032-23
27. Moshiri M, Etemad L, Javidi S, Alizadeh A. Peganum
harmala intoxication, a case report. Avicenna J Phytomed. 37. Solis-Herrera C, Kane MP, Triplitt C. Current understanding
2013;3(3):288-292. of sodium N-(8-[2-Hydroxylbenzoyl] Amino) caprylate
(SNAC) as an absorption enhancer: The oral semaglutide
28. Mahapatra MK, Karuppasamy M, Sahoo BM. Semaglutide, a experience. Clin Diabetes. 2024;42(1):74-86.
glucagon like peptide-1 receptor agonist with cardiovascular
benefits for management of type 2 diabetes. Rev Endocr doi: 10.2337/cd22-0118
Metab Disord. 2022;23(3):521-539. 38. Monti G, Gomes Moreira D, Richner M,
Mutsaers HAM, Ferreira N, Jan A. GLP-1 receptor agonists
doi: 10.1007/s11154-021-09699-1
in neurodegeneration: Neurovascular unit in the spotlight.
29. Draznin B. Molecular mechanisms of insulin resistance: Cells. 2022;11(13):2023.
Serine phosphorylation of insulin receptor substrate-1 and doi: 10.3390/cells11132023
increased expression of p85alpha: The two sides of a coin.
Diabetes. 2006;55(8):2392-2397. 39. Ahmed A, Monir Akl M. Exploring a synergistic approach:
Dual GLP-1 agonist combined with degludec basal insulin
doi: 10.2337/db06-0391 for early type 1 diabetes treatment and its impact on
30. Tekşen Y, Gündüz MK, Berikten D, Özatik FY, Aydın albumin-insulin producing cells expression. Adv Pharm
HE. Peganum harmala L. seed extract attenuates anxiety Bull. 2024;14(2):262-265.
and depression in rats by reducing neuroinflammation doi: 10.34172/apb.2024.040
and restoring the BDNF/TrkB signaling pathway and
monoamines after exposure to chronic unpredictable mild 40. Ghanbari A, Jalili C, Shahveisi K, Akhshi N. Harmine
stress. Metab Brain Dis. 2024;39(8):1523-1541. exhibits anti-apoptotic properties and reduces diabetes-
induced testicular damage caused by streptozotocin in rats.
doi: 10.1007/s11011-024-01416-6 Clin Exp Reprod Med. 2024;51(4):324-333.
31. Fornes A, Huff J, Pritchard RI, Godfrey M. Once-weekly doi: 10.5653/cerm.2023.06254
semaglutide for weight management: A clinical review.
J Pharm Technol. 2022;38(4):239-246. 41. Yu L, Shen N, Ren J, Xin H, Cui Y. Resource distribution,
pharmacological activity, toxicology and clinical drugs of
doi: 10.1177/87551225221092681 β-Carboline alkaloids: An updated and systematic review.
32. Title AC, Karsai M, Mir-Coll J, et al. Evaluation of the Fitoterapia. 2025;180:106326.
effects of harmine on β-cell function and proliferation doi: 10.1016/j.fitote.2024.106326

Volume 2 Issue 3 (2025) 67 doi: 10.36922/IMO025060009